Letter: Addressing Gaps in Hospital-Based Hepatitis C Screening—Insights and Recommendations

IF 6.7 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Alimentary Pharmacology & Therapeutics Pub Date : 2025-01-16 DOI:10.1111/apt.18460
Zhen Deng, Lincheng Duan, Kai Wang
{"title":"Letter: Addressing Gaps in Hospital-Based Hepatitis C Screening—Insights and Recommendations","authors":"Zhen Deng,&nbsp;Lincheng Duan,&nbsp;Kai Wang","doi":"10.1111/apt.18460","DOIUrl":null,"url":null,"abstract":"<p>We have carefully reviewed Ferrarese et al.'s study on the effectiveness of hospital-based hepatitis C virus (HCV) screening activities [<span>1</span>]. This research offers crucial data for identifying HCV-infected patients beyond current national screening policies, and provides valuable insights for public health interventions. However, we propose several considerations and recommendations to enhance the study.</p><p>Firstly, the study does not sufficiently analyse patients' comorbid conditions. Hospitalised patients often have chronic diseases such as diabetes, metabolic syndrome or cardiovascular diseases, which increase HCV infection risk and influence treatment adherence and outcomes [<span>2, 3</span>]. Stratified analysis by comorbidities could clarify the interplay between HCV infection and overall health, aiding in the development of targeted screening and treatment strategies.</p><p>Secondly, the research inadequately addresses patients' socioeconomic status (SES), a key factor affecting healthcare access and screening participation [<span>4, 5</span>]. Individuals with low-income or education levels may encounter greater barriers due to financial constraints or lack of information [<span>6</span>]. Collecting data on income, education and employment, and examining their impact on screening and treatment, would provide a more comprehensive understanding of how socioeconomic disparities impede HCV prevention and control.</p><p>Thirdly, while the study notes that 82.5% of hospitalised patients were not screened, it does not examine the specific characteristics of this unscreened group, such as age, gender, comorbidities or departmental distribution. This selection bias may limit the representativeness of the findings. We recommend a retrospective analysis of hospital records to identify traits of the unscreened population, enabling a more accurate assessment of HCV prevalence among hospitalised patients and the creation of more inclusive screening strategies.</p><p>Additionally, the study finds that female patients with positive viral loads are significantly older than males, while it does not explore the reasons for this gender disparity. This difference might relate to unique risk factors for disease progression in women or barriers to healthcare access. Future research should investigate this phenomenon to optimise screening and treatment approaches for female patients.</p><p>Lastly, the study mentions that some patients were lost to follow-up after referral to local centres but does not suggest specific improvements for follow-up management. Loss to follow-up can severely impact treatment outcomes, particularly for foreign patients or those with limited medical resources. To address these issues comprehensively, we suggest integrating social work practices to enhance HCV screening and treatment effectiveness. Health education and outreach through community lectures and multilingual support can help high-risk groups understand the importance of screening and overcome cultural or language barriers. Providing financial assistance or mobile screening services for low-income or resource-limited populations can reduce participation barriers. For foreign and female patients, culturally adapted educational materials, flexible screening schedules and childcare services can offer targeted support. Additionally, case management models and digital follow-up tools can improve long-term adherence, while establishing patient support groups and advocating for policy enhancements (such as expanding free screening coverage) can create synergistic effects from grassroots to policy levels.</p><p>In conclusion, Ferrarese et al. have significantly advanced HCV screening efforts. Addressing the aforementioned issues would enhance the study's credibility and practical applicability, providing more comprehensive scientific support for optimising screening and treatment strategies.</p><p><b>Zhen Deng:</b> methodology, formal analysis, writing – original draft. <b>Lincheng Duan:</b> methodology, writing – original draft. <b>Kai Wang:</b> conceptualization, methodology, supervision, writing – review and editing.</p><p>The authors declare no conflicts of interest.</p><p>This article is linked to Ferrarese et al papers. To view these articles, visit https://doi.org/10.1111/apt.18433 and https://doi.org/10.1111/apt.18505.</p>","PeriodicalId":121,"journal":{"name":"Alimentary Pharmacology & Therapeutics","volume":"61 5","pages":"915-916"},"PeriodicalIF":6.7000,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apt.18460","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alimentary Pharmacology & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/apt.18460","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

We have carefully reviewed Ferrarese et al.'s study on the effectiveness of hospital-based hepatitis C virus (HCV) screening activities [1]. This research offers crucial data for identifying HCV-infected patients beyond current national screening policies, and provides valuable insights for public health interventions. However, we propose several considerations and recommendations to enhance the study.

Firstly, the study does not sufficiently analyse patients' comorbid conditions. Hospitalised patients often have chronic diseases such as diabetes, metabolic syndrome or cardiovascular diseases, which increase HCV infection risk and influence treatment adherence and outcomes [2, 3]. Stratified analysis by comorbidities could clarify the interplay between HCV infection and overall health, aiding in the development of targeted screening and treatment strategies.

Secondly, the research inadequately addresses patients' socioeconomic status (SES), a key factor affecting healthcare access and screening participation [4, 5]. Individuals with low-income or education levels may encounter greater barriers due to financial constraints or lack of information [6]. Collecting data on income, education and employment, and examining their impact on screening and treatment, would provide a more comprehensive understanding of how socioeconomic disparities impede HCV prevention and control.

Thirdly, while the study notes that 82.5% of hospitalised patients were not screened, it does not examine the specific characteristics of this unscreened group, such as age, gender, comorbidities or departmental distribution. This selection bias may limit the representativeness of the findings. We recommend a retrospective analysis of hospital records to identify traits of the unscreened population, enabling a more accurate assessment of HCV prevalence among hospitalised patients and the creation of more inclusive screening strategies.

Additionally, the study finds that female patients with positive viral loads are significantly older than males, while it does not explore the reasons for this gender disparity. This difference might relate to unique risk factors for disease progression in women or barriers to healthcare access. Future research should investigate this phenomenon to optimise screening and treatment approaches for female patients.

Lastly, the study mentions that some patients were lost to follow-up after referral to local centres but does not suggest specific improvements for follow-up management. Loss to follow-up can severely impact treatment outcomes, particularly for foreign patients or those with limited medical resources. To address these issues comprehensively, we suggest integrating social work practices to enhance HCV screening and treatment effectiveness. Health education and outreach through community lectures and multilingual support can help high-risk groups understand the importance of screening and overcome cultural or language barriers. Providing financial assistance or mobile screening services for low-income or resource-limited populations can reduce participation barriers. For foreign and female patients, culturally adapted educational materials, flexible screening schedules and childcare services can offer targeted support. Additionally, case management models and digital follow-up tools can improve long-term adherence, while establishing patient support groups and advocating for policy enhancements (such as expanding free screening coverage) can create synergistic effects from grassroots to policy levels.

In conclusion, Ferrarese et al. have significantly advanced HCV screening efforts. Addressing the aforementioned issues would enhance the study's credibility and practical applicability, providing more comprehensive scientific support for optimising screening and treatment strategies.

Zhen Deng: methodology, formal analysis, writing – original draft. Lincheng Duan: methodology, writing – original draft. Kai Wang: conceptualization, methodology, supervision, writing – review and editing.

The authors declare no conflicts of interest.

This article is linked to Ferrarese et al papers. To view these articles, visit https://doi.org/10.1111/apt.18433 and https://doi.org/10.1111/apt.18505.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
信函:解决以医院为基础的丙型肝炎筛查的差距——见解和建议
我们仔细回顾了Ferrarese等人关于医院丙型肝炎病毒(HCV)筛查活动有效性的研究[10]。这项研究为识别hcv感染患者提供了重要的数据,超出了目前的国家筛查政策,并为公共卫生干预提供了有价值的见解。然而,我们提出了几点考虑和建议,以加强研究。首先,该研究没有充分分析患者的合并症。住院患者通常患有慢性疾病,如糖尿病、代谢综合征或心血管疾病,这增加了HCV感染的风险,并影响治疗依从性和结果[2,3]。按合并症进行分层分析可以阐明HCV感染与整体健康之间的相互作用,有助于制定有针对性的筛查和治疗策略。其次,该研究没有充分考虑患者的社会经济地位(SES),这是影响医疗保健获取和筛查参与的关键因素[4,5]。低收入或受教育程度较低的个人可能由于经济拮据或缺乏信息而遇到更大的障碍。收集有关收入、教育和就业的数据,并检查其对筛查和治疗的影响,将有助于更全面地了解社会经济差异如何阻碍丙型肝炎病毒的预防和控制。第三,虽然该研究指出82.5%的住院患者没有接受筛查,但它没有检查这一未接受筛查的群体的具体特征,如年龄、性别、合并症或部门分布。这种选择偏差可能会限制研究结果的代表性。我们建议对医院记录进行回顾性分析,以确定未筛查人群的特征,从而更准确地评估住院患者的HCV患病率,并制定更具包容性的筛查策略。此外,研究发现病毒载量阳性的女性患者明显比男性年龄大,但没有探讨这种性别差异的原因。这种差异可能与妇女疾病进展的独特风险因素或获得医疗保健的障碍有关。未来的研究应探讨这一现象,以优化女性患者的筛查和治疗方法。最后,该研究提到一些患者在转诊到当地中心后失去了随访,但没有提出具体的随访管理改进建议。失去随访可严重影响治疗结果,特别是对外国患者或医疗资源有限的患者。为了全面解决这些问题,我们建议结合社会工作实践来提高HCV的筛查和治疗效果。通过社区讲座和多语言支持开展健康教育和外联活动,可以帮助高危群体了解筛查的重要性,并克服文化或语言障碍。为低收入或资源有限的人群提供财政援助或流动筛查服务可以减少参与障碍。对于外国和女性患者,适应文化的教育材料、灵活的筛查时间表和托儿服务可以提供有针对性的支持。此外,病例管理模式和数字随访工具可以改善长期依从性,同时建立患者支持小组和倡导加强政策(如扩大免费筛查覆盖范围)可以从基层到政策层面产生协同效应。总之,Ferrarese等人在HCV筛查方面取得了显著进展。解决上述问题将提高研究的可信度和实际适用性,为优化筛查和治疗策略提供更全面的科学支持。邓震:方法论,形式分析,写作-原稿。段林成:方法论,写作-原稿。王凯:概念、方法、监督、写作、审稿、编辑。作者声明无利益冲突。这篇文章链接到Ferrarese等人的论文。要查看这些文章,请访问https://doi.org/10.1111/apt.18433和https://doi.org/10.1111/apt.18505。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
15.60
自引率
7.90%
发文量
527
审稿时长
3-6 weeks
期刊介绍: Alimentary Pharmacology & Therapeutics is a global pharmacology journal focused on the impact of drugs on the human gastrointestinal and hepato-biliary systems. It covers a diverse range of topics, often with immediate clinical relevance to its readership.
期刊最新文献
Letter: Intestinal Ultrasound-Prioritising Progress. Letter: Attempted Validation of Villin-1 as a Gut Barrier Marker in Decompensated Cirrhosis-Potential Confounding by Tubular Injury and Aetiology. Letter: Does Serum HBV RNA Add Incremental Value for Hepatocellular Carcinoma Risk Stratification Beyond Established Predictors? Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease. Authors' Reply. Letter: Does Serum HBV RNA Add Incremental Value for Hepatocellular Carcinoma Risk Stratification Beyond Established Predictors? Authors' Reply.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1